Safety, Tolerability, and Antitumor Activity of Zipalertinib Among Patients With Non-Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 20 Insertions.
Zofia PiotrowskaDaniel Shao-Weng TanEgbert F SmitAlexander I SpiraRoss Andrew SooDanny NguyenVictor Ho Fun LeeJames Chih-Hsin YangVamsidhar VelchetiJohn M WrangleMark A SocinskiMarianna KoczywasJohn E JanikJeffrey JonesHelena Alexandra YuPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
ex20ins-mutant NSCLC, with an acceptable safety profile, including low frequency of high-grade diarrhea and rash.